— Know what they know.
Not Investment Advice
Also trades as: 0I0X.L (LSE) · $vol 0M

CDXS NASDAQ

Codexis, Inc.
1W: -1.6% 1M: +2.4% 3M: +116.2% YTD: +57.1% 1Y: +3.3% 3Y: -3.4% 5Y: -86.2%
$2.49
-0.04 (-1.58%)
 
Weekly Expected Move ±11.6%
$2 $2 $2 $3 $3
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 48 · $226.3M mcap · 73M float · 3.25% daily turnover · Short 42% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
42.7 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -44.9%  ·  5Y Avg: -92.8%
Cost Advantage ★
54
Intangibles
44
Switching Cost
47
Network Effect
39
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CDXS shows a Weak competitive edge (42.7/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. Negative ROIC of -44.9% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$5
Avg Target
$5
High
Based on 1 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 9Hold: 5Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$5.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-03-12 Stifel Nicolaus Daniel Arias Initiated $5 +194.1% $1.70
2024-05-30 Cantor Fitzgerald Kristen Kluska Initiated $11 +244.8% $3.19

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CDXS receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-08 C- D+
2026-05-04 D+ C-
2026-04-22 C- D+
2026-04-01 D+ C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

34 Grade D
Profitability
20
Balance Sheet
41
Earnings Quality
51
Growth
88
Value
29
Momentum
80
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CDXS scores highest in Growth (88/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-4.30
Distress Zone
Piotroski F-Score
4/9
Beneish M-Score
-2.64
Unlikely Manipulator
Ohlson O-Score
-4.74
Bankruptcy prob: 0.9%
Low Risk
Credit Rating
B
Score: 27.4/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.59x
Accruals: -8.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CDXS scores -4.30, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CDXS scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CDXS's score of -2.64 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CDXS's implied 0.9% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CDXS receives an estimated rating of B (score: 27.4/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-7.07x
PEG
-0.06x
P/S
2.90x
P/B
5.23x
P/FCF
-6.69x
P/OCF
EV/EBITDA
-8.01x
EV/Revenue
1.83x
EV/EBIT
-5.57x
EV/FCF
-6.46x
Earnings Yield
-21.62%
FCF Yield
-14.95%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CDXS currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.002
NI / EBT
×
Interest Burden
1.244
EBT / EBIT
×
EBIT Margin
-0.329
EBIT / Rev
×
Asset Turnover
0.526
Rev / Assets
×
Equity Multiplier
2.527
Assets / Equity
=
ROE
-54.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CDXS's ROE of -54.5% is driven by Asset Turnover (0.526), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$2.49
Median 1Y
$1.37
5th Pctile
$0.36
95th Pctile
$5.32
Ann. Volatility
78.4%
Analyst Target
$5.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Alison Moore, Ph.D.
President and Chief Executive Officer
$524,732 $255,994 $2,323,279
Stephen G. Dilly,
M.B.B.S., Ph.D. Executive Chair of the Board of Directors and former President and Chief Executive Officer
$758,903 $374,954 $2,194,601
Georgia Erbez Financial
ancial Officer and Chief Business Officer
$507,423 $117,444 $1,350,930
Kevin Norrett, M.B.A.
Former Chief Operating Officer
$501,298 $57,306 $1,333,906
Stefan Lutz, Ph.D.
Chief Scientific Officer
$481,572 $76,475 $1,123,094

CEO Pay Ratio

7:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $2,323,279
Avg Employee Cost (SGA/emp): $322,425
Employees: 146

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
146
-22.3% YoY
Revenue / Employee
$482,103
Rev: $70,387,000
Profit / Employee
$-301,192
NI: $-43,974,000
SGA / Employee
$322,425
Avg labor cost proxy
R&D / Employee
$303,829
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -16.9% -10.9% -12.7% -12.3% -11.3% -18.6% -21.7% -31.0% -36.7% -52.8% -65.9% -56.3% -66.0% -53.7% -85.0% -97.0% -84.6% -83.3% -74.9% -54.5% -54.47%
ROA -12.6% -8.1% -9.1% -8.8% -8.1% -13.3% -13.5% -19.3% -22.8% -32.9% -39.4% -33.7% -39.5% -32.1% -45.7% -52.1% -45.5% -44.8% -29.6% -21.6% -21.56%
ROIC -41.5% -28.5% -18.8% -18.2% -16.6% -26.6% -37.0% -53.2% -63.9% -86.6% -1.4% -1.2% -1.4% -1.1% -86.6% -99.4% -84.7% -88.3% -66.5% -44.9% -44.92%
ROCE -12.0% -8.3% -10.7% -10.3% -9.4% -15.0% -15.8% -23.3% -27.7% -31.8% -53.4% -41.7% -51.9% -48.7% -47.6% -54.7% -47.9% -50.0% -31.3% -20.9% -20.95%
Gross Margin 83.0% 81.3% 72.2% 75.9% 70.7% 71.6% 72.2% 65.2% 85.1% 75.8% 84.6% 64.2% 56.6% 66.4% 83.0% 63.8% 86.3% 71.3% 91.4% 78.3% 78.28%
Operating Margin -17.6% 3.6% -42.4% -23.7% -6.8% -30.9% -43.6% -1.8% -59.2% -3.5% 1.1% -69.6% -2.8% -1.3% -34.2% -2.7% -83.9% -2.2% 35.9% -52.7% -52.75%
Net Margin -16.8% 6.1% -41.6% -23.6% -6.9% -29.0% -41.5% -1.7% -54.0% -3.8% -27.1% -67.4% -2.9% -1.6% -48.4% -2.7% -86.6% -2.3% 24.7% -57.1% -57.08%
EBITDA Margin -12.2% 7.5% -34.9% -16.9% -0.2% -23.3% -24.4% -1.6% -41.1% -1.8% 8.5% -57.8% -2.5% -1.1% -38.6% -2.5% -78.0% -1.9% 41.6% -38.2% -38.18%
FCF Margin -31.7% -25.9% -26.8% -29.0% -21.8% -5.1% 2.1% 6.5% -6.1% -56.0% -81.3% -73.0% -80.7% -71.6% -90.5% -1.2% -1.2% -1.2% -33.9% -28.3% -28.32%
OCF Margin -23.8% -16.2% -13.6% -15.6% -9.6% 5.3% 8.1% 11.4% -0.7% -49.6% -75.0% -69.0% -77.7% -68.2% -83.3% -1.1% -1.1% -1.1% -27.5% -24.0% -23.98%
ROE 3Y Avg snapshot only -83.25%
ROE 5Y Avg snapshot only -59.06%
ROA 3Y Avg snapshot only -39.77%
ROIC 3Y Avg snapshot only -1.07%
ROIC Economic snapshot only -16.74%
Cash ROA snapshot only -12.67%
Cash ROIC snapshot only -41.14%
CROIC snapshot only -48.58%
NOPAT Margin snapshot only -26.19%
Pretax Margin snapshot only -40.87%
R&D / Revenue snapshot only 39.67%
SGA / Revenue snapshot only 56.17%
SBC / Revenue snapshot only 7.89%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -62.54 -104.98 -95.39 -65.26 -36.05 -12.72 -9.09 -5.70 -3.33 -1.61 -2.78 -3.74 -2.86 -3.57 -5.94 -2.98 -3.21 -3.44 -3.37 -4.62 -7.065
P/S Ratio 17.61 15.56 19.38 11.00 5.06 2.99 2.20 2.35 1.91 1.78 3.02 3.28 3.58 3.44 6.53 4.45 3.64 4.16 2.11 1.89 2.898
P/B Ratio 8.58 9.26 12.35 8.17 4.15 2.41 2.11 1.89 1.31 0.91 2.45 2.81 2.52 2.56 5.79 3.31 3.11 3.29 2.93 2.93 5.228
P/FCF -55.51 -60.01 -72.25 -37.94 -23.22 -58.37 102.62 36.39 -31.30 -3.17 -3.72 -4.50 -4.44 -4.81 -7.22 -3.70 -3.07 -3.57 -6.21 -6.69 -6.689
P/OCF 56.42 27.07 20.59
EV/EBITDA -71.67 -132.77 -117.06 -85.60 -51.90 -14.48 -10.96 -5.57 -2.64 -1.14 -3.72 -5.93 -3.86 -4.21 -7.26 -3.44 -3.70 -3.74 -4.65 -8.01 -8.007
EV/Revenue 16.10 14.32 18.72 10.43 4.55 2.47 1.70 1.74 1.20 0.82 2.32 2.62 2.78 2.68 6.31 4.18 3.41 3.90 2.03 1.83 1.831
EV/EBIT -56.49 -89.34 -86.39 -58.06 -30.61 -10.22 -7.41 -4.32 -2.13 -0.95 -3.03 -4.63 -3.23 -3.52 -6.27 -3.04 -3.25 -3.30 -3.74 -5.57 -5.572
EV/FCF -50.75 -55.25 -69.79 -35.98 -20.87 -48.19 78.99 27.01 -19.66 -1.47 -2.85 -3.59 -3.44 -3.75 -6.97 -3.48 -2.87 -3.35 -6.00 -6.46 -6.463
Earnings Yield -1.6% -1.0% -1.0% -1.5% -2.8% -7.9% -11.0% -17.5% -30.0% -62.2% -36.0% -26.7% -35.0% -28.0% -16.8% -33.6% -31.2% -29.0% -29.7% -21.6% -21.62%
FCF Yield -1.8% -1.7% -1.4% -2.6% -4.3% -1.7% 1.0% 2.7% -3.2% -31.6% -26.9% -22.2% -22.5% -20.8% -13.9% -27.0% -32.5% -28.0% -16.1% -15.0% -14.95%
Price/Tangible Book snapshot only 3.078
EV/Gross Profit snapshot only 2.138
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 7.38 7.38 4.85 4.85 4.85 4.85 3.32 3.32 3.32 3.32 2.61 2.61 2.61 2.61 4.18 4.18 4.18 4.18 3.82 3.82 3.824
Quick Ratio 7.34 7.34 4.82 4.82 4.82 4.82 3.28 3.28 3.28 3.28 2.53 2.53 2.53 2.53 4.10 4.10 4.10 4.10 3.75 3.75 3.752
Debt/Equity 0.15 0.15 0.29 0.29 0.29 0.29 0.30 0.30 0.30 0.30 0.19 0.19 0.19 0.19 0.89 0.89 0.89 0.89 1.45 1.45 1.449
Net Debt/Equity -0.74 -0.74 -0.42 -0.42 -0.42 -0.42 -0.49 -0.49 -0.49 -0.49 -0.57 -0.57 -0.57 -0.57 -0.20 -0.20 -0.20 -0.20 -0.10 -0.10 -0.099
Debt/Assets 0.11 0.11 0.19 0.19 0.19 0.19 0.17 0.17 0.17 0.17 0.12 0.12 0.12 0.12 0.40 0.40 0.40 0.40 0.50 0.50 0.495
Debt/EBITDA -1.34 -2.28 -2.85 -3.20 -4.03 -2.11 -2.03 -1.20 -0.97 -0.82 -0.37 -0.49 -0.37 -0.39 -1.16 -0.99 -1.14 -1.08 -2.38 -4.10 -4.101
Net Debt/EBITDA 6.72 11.46 4.13 4.65 5.85 3.06 3.28 1.93 1.56 1.31 1.12 1.50 1.12 1.20 0.26 0.22 0.26 0.25 0.16 0.28 0.280
Interest Coverage -6201.89 -7124.11 -5972.56 -4672.00 -53.10 -8.31 -116.20 -160.09 -140.56 -19.55 -11.90 -11.27 -11.272
Equity Multiplier 1.30 1.30 1.50 1.50 1.50 1.50 1.73 1.73 1.73 1.73 1.58 1.58 1.58 1.58 2.23 2.23 2.23 2.23 2.92 2.92 2.925
Cash Ratio snapshot only 3.089
Debt Service Coverage snapshot only -7.844
Cash to Debt snapshot only 1.068
FCF to Debt snapshot only -0.302
Defensive Interval snapshot only 350.0 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.45 0.55 0.45 0.52 0.58 0.57 0.56 0.47 0.40 0.30 0.36 0.38 0.31 0.33 0.42 0.35 0.40 0.37 0.47 0.53 0.526
Inventory Turnover 27.02 31.85 20.91 24.96 31.51 34.26 23.85 21.34 16.27 11.54 5.95 6.62 6.74 7.62 7.82 6.32 5.71 4.88 5.89 6.22 6.215
Receivables Turnover 3.35 4.10 3.89 4.54 5.02 4.93 4.93 4.13 3.52 2.63 3.36 3.56 2.92 3.09 5.46 4.59 5.26 4.87 6.26 6.95 6.946
Payables Turnover 6.45 7.61 7.45 8.89 11.22 12.20 12.19 10.91 8.31 5.90 3.05 3.40 3.46 3.91 3.99 3.22 2.91 2.49 4.85 5.12 5.117
DSO 109 89 94 80 73 74 74 88 104 139 109 103 125 118 67 80 69 75 58 53 52.6 days
DIO 14 11 17 15 12 11 15 17 22 32 61 55 54 48 47 58 64 75 62 59 58.7 days
DPO 57 48 49 41 33 30 30 33 44 62 120 107 106 93 91 113 125 146 75 71 71.3 days
Cash Conversion Cycle 66 53 62 54 52 55 59 72 82 109 50 50 74 73 22 24 8 3 45 40 39.9 days
Fixed Asset Turnover snapshot only 1.794
Operating Cycle snapshot only 111.3 days
Cash Velocity snapshot only 0.999
Capital Intensity snapshot only 1.893
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 18.1% 51.9% 51.7% 68.6% 62.9% 31.0% 32.3% -4.8% -26.6% -44.3% -49.4% -36.1% -38.6% -12.9% -15.4% -32.9% -6.1% -17.9% 18.6% 56.8% 56.76%
Net Income -63.4% 27.6% 11.4% 19.1% 18.9% -1.1% -57.9% -1.3% -2.0% -1.6% -1.3% -36.1% -34.6% 24.0% 14.4% -14.3% 14.9% -3.0% 32.6% 57.0% 57.04%
EPS -49.6% 36.9% 17.4% 20.1% 19.9% -1.2% -56.3% -1.3% -1.9% -1.5% -1.1% -28.5% -29.2% 26.7% 26.8% 3.1% 29.9% 17.8% 39.8% 61.0% 60.99%
FCF -30.8% -23.2% -39.0% -31.0% -11.8% 74.1% 1.1% 1.2% 79.4% -5.1% -20.2% -8.2% -7.1% -11.3% 5.9% -10.4% -38.0% -33.7% 55.6% 63.0% 63.04%
EBITDA -87.6% 33.3% 13.5% 27.5% 36.5% -1.1% -28.1% -1.4% -2.8% -1.4% -1.0% 9.8% 2.9% 23.4% -17.6% -84.2% -20.4% -34.8% 40.2% 70.5% 70.46%
Op. Income -61.6% 22.5% 5.1% 13.2% 15.1% -97.2% -53.7% -1.3% -2.0% -1.5% -95.1% -12.2% -10.3% 37.6% 14.0% -19.2% 13.8% -17.2% 34.5% 61.4% 61.43%
OCF Growth snapshot only 66.21%
Asset Growth snapshot only -0.81%
Equity Growth snapshot only -24.50%
Debt Growth snapshot only 22.23%
Shares Change snapshot only 10.14%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 11.8% 15.2% 20.0% 25.2% 30.4% 26.3% 26.5% 19.8% 12.2% 3.5% 0.5% 0.8% -9.8% -14.0% -17.3% -25.8% -24.9% -26.4% -20.2% -12.4% -12.42%
Revenue 5Y 9.4% 15.0% 16.5% 20.1% 25.6% 28.2% 22.6% 15.7% 10.8% 2.2% 3.0% 3.6% -0.0% -0.4% -2.8% -5.9% -4.0% -4.5% 0.4% 1.5% 1.52%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 12.7% 15.1% 19.8% 25.0% 28.8% 23.4% 23.9% 15.2% 8.4% 0.1% 0.5% 0.9% -11.5% -16.6% -20.3% -28.0% -24.1% -24.2% -15.9% -6.7% -6.66%
Gross Profit 5Y 7.9% 14.6% 16.1% 19.9% 26.5% 30.7% 23.0% 15.0% 10.1% 1.2% 3.2% 3.7% -1.1% -1.9% -4.6% -7.9% -5.1% -5.4% 1.5% 3.2% 3.24%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 60.5% 60.5% 46.5% 46.5% 46.5% 46.5% 18.9% 18.9% 18.9% 18.9% -14.9% -14.9% -14.9% -14.9% -15.4% -15.4% -15.4% -15.4% -16.1% -16.1% -16.12%
Assets 5Y 37.8% 37.8% 47.2% 47.2% 47.2% 47.2% 36.1% 36.1% 36.1% 36.1% 11.8% 11.8% 11.8% 11.8% -0.0% -0.0% -0.0% -0.0% -7.8% -7.8% -7.79%
Equity 3Y 90.7% 90.7% 42.9% 42.9% 42.9% 42.9% 11.1% 11.1% 11.1% 11.1% -20.1% -20.1% -20.1% -20.1% -25.9% -25.9% -25.9% -25.9% -29.6% -29.6% -29.60%
Book Value 3Y 78.4% 76.3% 34.4% 34.4% 34.9% 39.9% 7.1% 7.0% 6.2% 5.3% -23.8% -22.3% -22.5% -21.8% -31.2% -31.5% -32.2% -33.4% -36.9% -36.7% -36.71%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.86 0.71 0.78 0.72 0.81 0.90 0.84 0.79 0.59 0.22 0.22 0.20 0.03 0.00 0.02 0.07 0.12 0.12 0.07 0.07 0.071
Earnings Stability 0.49 0.02 0.28 0.42 0.14 0.04 0.37 0.53 0.51 0.66 0.73 0.84 0.78 0.72 0.80 0.91 0.81 0.65 0.43 0.26 0.264
Margin Stability 0.96 0.98 0.98 0.99 0.95 0.91 0.95 0.95 0.96 0.95 0.96 0.95 0.97 0.96 0.95 0.94 0.96 0.94 0.92 0.92 0.921
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.50 0.00 1.00 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.89 0.95 0.92 0.92 0.50 0.50 0.50 0.50 0.50 0.50 0.86 0.86 0.90 0.94 0.94 0.94 0.99 0.87 0.50 0.500
Earnings Smoothness
ROE Trend 0.06 0.11 -0.00 0.02 0.02 -0.05 -0.10 -0.19 -0.27 -0.42 -0.70 -0.52 -0.63 -0.34 -0.42 -0.57 -0.33 -0.32 0.06 0.30 0.299
Gross Margin Trend -0.02 -0.01 0.00 -0.01 -0.05 -0.08 -0.07 -0.08 -0.03 -0.01 0.04 0.04 -0.01 -0.02 -0.06 -0.03 0.04 0.06 0.10 0.10 0.103
FCF Margin Trend -0.07 0.00 -0.00 0.01 0.08 0.24 0.30 0.40 0.21 -0.41 -0.69 -0.62 -0.67 -0.41 -0.51 -0.87 -0.75 -0.53 0.52 0.68 0.683
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.84 1.09 0.67 0.92 0.68 -0.23 -0.34 -0.28 0.01 0.45 0.69 0.79 0.62 0.71 0.76 0.74 0.94 0.87 0.44 0.59 0.585
FCF/OCF 1.34 1.60 1.97 1.86 2.28 -0.97 0.26 0.57 9.33 1.13 1.08 1.06 1.04 1.05 1.09 1.08 1.11 1.10 1.23 1.18 1.181
FCF/Net Income snapshot only 0.691
CapEx/Revenue 8.0% 9.7% 13.2% 13.4% 12.2% 10.4% 6.0% 5.0% 5.4% 6.4% 6.3% 4.1% 3.0% 3.3% 7.3% 8.9% 11.5% 10.8% 6.4% 4.3% 4.34%
CapEx/Depreciation snapshot only 0.435
Accruals Ratio -0.02 0.01 -0.03 -0.01 -0.03 -0.16 -0.18 -0.25 -0.23 -0.18 -0.12 -0.07 -0.15 -0.09 -0.11 -0.13 -0.03 -0.06 -0.17 -0.09 -0.089
Sloan Accruals snapshot only -0.077
Cash Flow Adequacy snapshot only -5.523
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0% 0.0%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -6.0% -5.6% -0.1% -0.0% -0.0% -0.1% -0.2% -0.8% -4.7% -6.8% -4.0% -3.0% -0.0% -14.2% -8.1% -14.6% -23.7% -8.1% -12.2% -11.4% -11.45%
Total Shareholder Return -6.0% -5.6% -0.1% -0.0% -0.0% -0.1% -0.2% -0.8% -4.7% -6.8% -4.0% -3.0% -0.0% -14.2% -8.1% -14.6% -23.7% -8.1% -12.2% -11.4% -11.45%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.01 1.01 1.01 1.02 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.002
Interest Burden (EBT/EBIT) 0.99 0.92 0.93 0.93 0.93 0.97 1.05 1.01 1.01 1.27 1.42 1.55 1.46 1.26 1.09 1.09 1.08 1.02 1.15 1.24 1.244
EBIT Margin -0.29 -0.16 -0.22 -0.18 -0.15 -0.24 -0.23 -0.40 -0.56 -0.87 -0.77 -0.57 -0.86 -0.76 -1.01 -1.38 -1.05 -1.18 -0.54 -0.33 -0.329
Asset Turnover 0.45 0.55 0.45 0.52 0.58 0.57 0.56 0.47 0.40 0.30 0.36 0.38 0.31 0.33 0.42 0.35 0.40 0.37 0.47 0.53 0.526
Equity Multiplier 1.35 1.35 1.40 1.40 1.40 1.40 1.61 1.61 1.61 1.61 1.67 1.67 1.67 1.67 1.86 1.86 1.86 1.86 2.53 2.53 2.527
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.36 $-0.22 $-0.33 $-0.32 $-0.29 $-0.48 $-0.51 $-0.73 $-0.84 $-1.18 $-1.10 $-0.93 $-1.09 $-0.86 $-0.80 $-0.90 $-0.76 $-0.71 $-0.48 $-0.35 $-0.35
Book Value/Share $2.64 $2.51 $2.53 $2.53 $2.52 $2.51 $2.21 $2.20 $2.14 $2.08 $1.25 $1.24 $1.23 $1.20 $0.82 $0.81 $0.78 $0.74 $0.56 $0.56 $0.48
Tangible Book/Share $2.59 $2.46 $2.48 $2.48 $2.47 $2.46 $2.16 $2.15 $2.09 $2.04 $1.21 $1.20 $1.20 $1.17 $0.79 $0.78 $0.75 $0.71 $0.53 $0.53 $0.53
Revenue/Share $1.29 $1.50 $1.61 $1.88 $2.07 $2.03 $2.11 $1.76 $1.47 $1.06 $1.01 $1.06 $0.87 $0.89 $0.73 $0.60 $0.67 $0.59 $0.77 $0.86 $0.86
FCF/Share $-0.41 $-0.39 $-0.43 $-0.54 $-0.45 $-0.10 $0.05 $0.11 $-0.09 $-0.60 $-0.82 $-0.78 $-0.70 $-0.64 $-0.66 $-0.73 $-0.79 $-0.68 $-0.26 $-0.24 $-0.24
OCF/Share $-0.31 $-0.24 $-0.22 $-0.29 $-0.20 $0.11 $0.17 $0.20 $-0.01 $-0.53 $-0.76 $-0.73 $-0.67 $-0.61 $-0.61 $-0.67 $-0.72 $-0.62 $-0.21 $-0.21 $-0.21
Cash/Share $2.33 $2.22 $1.80 $1.79 $1.79 $1.79 $1.74 $1.73 $1.69 $1.64 $0.94 $0.93 $0.93 $0.90 $0.90 $0.89 $0.86 $0.81 $0.86 $0.86 $0.72
EBITDA/Share $-0.29 $-0.16 $-0.26 $-0.23 $-0.18 $-0.35 $-0.33 $-0.55 $-0.67 $-0.77 $-0.63 $-0.47 $-0.62 $-0.57 $-0.63 $-0.73 $-0.62 $-0.61 $-0.34 $-0.20 $-0.20
Debt/Share $0.39 $0.37 $0.73 $0.73 $0.73 $0.73 $0.67 $0.66 $0.65 $0.63 $0.23 $0.23 $0.23 $0.22 $0.74 $0.73 $0.70 $0.66 $0.81 $0.81 $0.81
Net Debt/Share $-1.94 $-1.85 $-1.07 $-1.06 $-1.06 $-1.06 $-1.07 $-1.07 $-1.04 $-1.01 $-0.71 $-0.70 $-0.70 $-0.68 $-0.17 $-0.16 $-0.16 $-0.15 $-0.06 $-0.06 $-0.06
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -4.299
Altman Z-Prime snapshot only -9.780
Piotroski F-Score 2 4 5 4 4 5 4 3 3 3 2 1 1 3 4 3 5 5 4 4 4
Beneish M-Score -1.94 -1.71 -1.62 -1.14 -1.33 -2.09 -3.06 -2.45 -3.22 -1.48 -4.15 -3.44 -4.11 -3.50 -3.25 -2.92 -2.51 -2.91 -3.11 -2.64 -2.636
Ohlson O-Score snapshot only -4.737
ROIC (Greenblatt) snapshot only -22.30%
Net-Net WC snapshot only $-0.00
EVA snapshot only $-25005109.21
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B
Credit Score 74.02 73.71 73.21 73.86 71.92 52.84 53.12 49.07 31.37 31.65 32.86 32.95 32.70 32.78 29.70 29.56 29.35 29.38 27.52 27.39 27.387
Credit Grade snapshot only 15
Credit Trend snapshot only -2.169
Implied Spread (bps) snapshot only 750.000
Industry Credit Rank snapshot only 16
Sector Credit Rank snapshot only 16

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms